Bo Pang

688 total citations
26 papers, 462 citations indexed

About

Bo Pang is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Pang has authored 26 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Pang's work include Reproductive System and Pregnancy (8 papers), Immune cells in cancer (6 papers) and Immune Cell Function and Interaction (4 papers). Bo Pang is often cited by papers focused on Reproductive System and Pregnancy (8 papers), Immune cells in cancer (6 papers) and Immune Cell Function and Interaction (4 papers). Bo Pang collaborates with scholars based in China, Saint Kitts and Nevis and Egypt. Bo Pang's co-authors include Huanfa Yi, Cong Hu, Zhen Yu, Zhanchuan Ma, Delin Zhu, Yan Li, Yong-Jun Liu, Tianxiang Pang, Hanyu Wang and Shan Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Bo Pang

25 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Pang China 13 175 142 104 77 59 26 462
Xueling Cui China 15 113 0.6× 382 2.7× 73 0.7× 84 1.1× 23 0.4× 41 631
Youlin Kuang China 13 139 0.8× 195 1.4× 93 0.9× 116 1.5× 16 0.3× 35 490
Soo‐Rim Kim South Korea 12 99 0.6× 171 1.2× 88 0.8× 120 1.6× 76 1.3× 24 397
Morteza Abouzaripour Iran 8 237 1.4× 191 1.3× 74 0.7× 162 2.1× 17 0.3× 15 526
Tadeja Kuret Slovenia 11 124 0.7× 118 0.8× 57 0.5× 22 0.3× 27 0.5× 26 394
Valentina Iannizzotto United Kingdom 8 154 0.9× 98 0.7× 27 0.3× 137 1.8× 40 0.7× 14 443
Wen Yuan China 10 138 0.8× 232 1.6× 137 1.3× 253 3.3× 39 0.7× 19 507
Isaiah G. Schauer United States 8 99 0.6× 176 1.2× 98 0.9× 127 1.6× 72 1.2× 9 481
Hima V. Vangapandu United States 12 49 0.3× 241 1.7× 89 0.9× 57 0.7× 32 0.5× 17 460
Ziqin Deng China 6 102 0.6× 178 1.3× 57 0.5× 84 1.1× 11 0.2× 12 486

Countries citing papers authored by Bo Pang

Since Specialization
Citations

This map shows the geographic impact of Bo Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Pang more than expected).

Fields of papers citing papers by Bo Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Pang. The network helps show where Bo Pang may publish in the future.

Co-authorship network of co-authors of Bo Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Pang. A scholar is included among the top collaborators of Bo Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Pang. Bo Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lu, et al.. (2024). Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC. Journal of Cancer Research and Clinical Oncology. 150(4). 198–198. 2 indexed citations
2.
Zhang, Chuanlong, Qian Shen, Mengqi Gao, Junchen Li, & Bo Pang. (2024). The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis. Heliyon. 10(4). e26061–e26061. 5 indexed citations
3.
Li, Qin, et al.. (2023). MALAT1 modulates trophoblast phenotype via miR-101–3p/VEGFA axis. Archives of Biochemistry and Biophysics. 744. 109692–109692. 8 indexed citations
4.
Pang, Bo, et al.. (2023). Myeloidderived suppressor cells: Escorts at the maternal–fetal interface. Frontiers in Immunology. 14. 1080391–1080391. 12 indexed citations
5.
Cheng, Xingbo, Bo Pang, Sen Wang, et al.. (2022). Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma. International Immunopharmacology. 104. 108399–108399. 5 indexed citations
6.
Hu, Cong, Zhen Yu, Zhanchuan Ma, et al.. (2022). Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression. Molecular Therapy. 31(2). 569–584. 13 indexed citations
7.
Wang, Jialin, Zhendong Liu, Cheng Zhang, et al.. (2021). Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients. PeerJ. 9. e10820–e10820. 7 indexed citations
8.
Pang, Bo, et al.. (2021). Supraphysiological estradiol promotes human T follicular helper cell differentiation and favours humoural immunity during in vitro fertilization. Journal of Cellular and Molecular Medicine. 25(14). 6524–6534. 6 indexed citations
9.
Pang, Bo, Ruichao Chai, Yuzhou Chang, et al.. (2021). A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery. European Spine Journal. 30(10). 2857–2866. 8 indexed citations
10.
Pang, Bo, et al.. (2021). Peritoneal well-differentiated papillary mesothelioma associated with infertility in a 37-year-old woman. Journal of International Medical Research. 49(1). 1220786232–1220786232.
11.
Chang, Xiaoyan, Pei Zhang, Xingxin Xu, & Bo Pang. (2021). Total Glucosides of Paeony Inhibited Autophagy and Improved Acute Kidney Injury Induced by Ischemia-Reperfusion via the lncRNA TUG1/miR-29a/PTEN Axis. Drug Design Development and Therapy. Volume 15. 2229–2242. 10 indexed citations
12.
Pang, Bo, Zhen Yu, Cong Hu, et al.. (2020). Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway. Clinical Science. 134(16). 2209–2222. 46 indexed citations
13.
Zhang, Zhihong, et al.. (2020). <p>Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis</p>. OncoTargets and Therapy. Volume 13. 6651–6660. 17 indexed citations
14.
Hu, Cong, et al.. (2020). <p>Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis</p>. Drug Design Development and Therapy. Volume 14. 4659–4670. 9 indexed citations
15.
Hu, Cong, et al.. (2019). Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells. British Journal of Cancer. 122(1). 23–29. 59 indexed citations
16.
Hu, Cong, et al.. (2019). Myeloid-Derived Suppressor Cells Are Regulated by Estradiol and Are a Predictive Marker for IVF Outcome. Frontiers in Endocrinology. 10. 521–521. 19 indexed citations
17.
Hu, Cong, et al.. (2019). Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p. Bioscience Reports. 39(5). 22 indexed citations
18.
Li, Jinyuan, Yuting Ji, Ming Ren, et al.. (2015). Inconclusive role of human papillomavirus infection in breast cancer. Infectious Agents and Cancer. 10(1). 36–36. 20 indexed citations
19.
Wang, Hanyu, Bo Pang, Yan Li, et al.. (2012). Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy. 14(4). 423–430. 60 indexed citations
20.
Park, Kyoung Sun, Bo Pang, Su Jung Park, et al.. (2011). Identification and Functional Characterization of Ion Channels in CD34+ Hematopoietic Stem Cells from Human Peripheral Blood. Molecules and Cells. 32(2). 181–188. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueling Cui Breakdown of academic impact, for papers by Youlin Kuang Breakdown of academic impact, for papers by Soo‐Rim Kim Breakdown of academic impact, for papers by Morteza Abouzaripour Breakdown of academic impact, for papers by Tadeja Kuret Breakdown of academic impact, for papers by Valentina Iannizzotto Breakdown of academic impact, for papers by Wen Yuan Breakdown of academic impact, for papers by Isaiah G. Schauer Breakdown of academic impact, for papers by Hima V. Vangapandu Breakdown of academic impact, for papers by Ziqin Deng
Rankless by CCL
2026